Finance

QIAGEN N.V.: QIAGEN Announces Strong Preliminary Q1 2025 Results and Updates Full-Year 2025 Adjusted Earnings per Share Outlook

https://www.investing.com/news/press-releases/qiagen-nv-qiagen-announces-strong-preliminary-q1-2025-results-and-updates-fullyear-2025-adjusted-earnings-per-share-outlook-93CH-3969539 Investing.com

Kentucky says 2 dead after floods, over dozen killed recently in other US parts

https://www.investing.com/news/world-news/kentucky-says-2-dead-after-floods-over-dozen-killed-recently-in-other-us-parts-3969540 Reuters

US sidelines DOJ lawyer after judge orders return of man deported erroneously

https://www.investing.com/news/world-news/us-sidelines-doj-lawyer-after-judge-orders-return-of-man-deported-erroneously-3969538 Reuters

Israeli military changes initial account of Gaza aid worker killings

https://www.investing.com/news/world-news/israeli-military-changes-initial-account-of-gaza-aid-worker-killings-3969508 Reuters

Turkey's opposition vows to sustain protests over jailing of Erdogan's main rival

https://www.investing.com/news/world-news/turkeys-opposition-vows-to-sustain-protests-over-jailing-of-erdogans-main-rival-3969536 Reuters

Rhythm Pharmaceuticals to Announce Topline Results from Pivotal Phase 3 TRANSCEND Trial Evaluating Setmelanotide in Patients with  Acquired Hypothalamic Obesity

https://www.investing.com/news/press-releases/rhythm-pharmaceuticals-to-announce-topline-results-from-pivotal-phase-3-transcend-trial-evaluating-setmelanotide-in-patients-with-acquired-hypothalamic-obesity-93CH-3969537 Investing.com

Latest articles

spot_imgspot_img